Birmingham Hip Resurfacing vs Total Hip Replacement by Smith & Nephew 2016… Read the rest
August 20, 2015
Previous data on the survivorship of the Birmingham Hip Resurfacing (BHR) implant have come from design surgeons and large national databases outside of the United States, and there is a lack of reported outcomes of surface replacement arthroplasty from US centers. A retrospective study was undertaken of 1271 hips treated with a BHR system (Smith & Nephew, Memphis, Tennessee) between June 2006 and September 2008 at 6 high-volume total joint centers in the United States. ..
…At 2 to 4 years of follow-up, the revision rate and the major complication rate with the … Read the rest
Matteo Cadossi, MD, PhD; Giuseppe Tedesco, MD; Andrea Sambri, MD; Antonio Mazzotti, MD; Sandro Giannini, MD
August 20, 2015
…Hip resurfacing offers a suitable solution for young patients affected by hip disease who have high function demands and good bone quality. Bone stock preservation, restoration of the normal proximal femur anatomy, the lack of stress shielding, and the possibility of resuming sporting activity are proven advantages of hip resurfacing. However, there are some disadvantages, such as fracture of the femoral neck, onset of neck narrowing,… Read the rest
Today marks the eighteenth year of the Birmingham Hip Resurfacing (BHR) in clinical use!
Dr. Brooks Study – 2,200 BHR Patients with 99% Survivorship 2014
December 12, 2014 Orlando FL
Read Complete Article Here:
"Resurfacing is very attractive to patients, less attractive to surgeons because
there are many ways to get into trouble. If you do it, if you do the deep dive,
you will become a better hip surgeon," Peter J. Brooks, MD, FRCS(C), said at the
Current Concepts in Joint Replacement Winter Meeting.
Brooks said in the mid-term results of study of more than 2,200 patients
implanted with the Birmingham Hip, there were few complications with no
dislocations or femoral … Read the rest
- Voluntary actions initiated to remove smaller size components
and change Instructions for Use (IFU) following analysis of recent
- No action required from patients; no change to current practice
for patient follow-up care
- BHR continues to perform amongst the best hip replacements for
the right patients
Smith & Nephew (LSE: SN; NYSE: SNN), the global medical technology
business, announces the voluntary removal from the market of 46mm
diameter and smaller femoral heads and corresponding acetabular cup
components for the
BIRMINGHAM HIP Resurfacing (BHR) System, and new
Instructions for Use (IFU), reflecting recent performance data. Surgeons
Yes, it is true.
Smith and Nephew was asked to respond to the long-known worse
outcomes in females. This was precipitated by the UK’s National Institute of
Clinical Excellence (NICE) raising their 10 year outcomes requirement from 90%
where it been for years, to 95%.
Raising the bar left females and small sizes below the bar
(along with a great many total hips as well, so expect more fall-out), and males
well above the bar.
If you remember, the UK registry, on which their regulators base decisions, had
an average doctor’s resurfacing volume of just 4 per year, … Read the rest
Smith & Nephew First Quarter 2012 Results
3 May 2012
…Revenue from our global Hip Implant franchise was down -2%. This was largely a result of continuing headwinds in the metal-on-metal total hip replacement sector. Sales of our BIRMINGHAM HIP◊ Resurfacing System ("BHR") continued to suffer from association, despite its strong track record demonstrated by many independent sources of data which have proved its performance over more than ten years. In traditional total hip implants we generated strong double-digit growth in revenue from products featuring our VERILAST bearing technology. We also launched the POLARCUP◊ Dual Mobility Hip System in … Read the rest
Hip Study: Smith & Nephew touts study results for new metal-on-metal implant
March 13, 2012 by MassDevice staff
Smith & Nephew unveils the results of its FDA-requested metal-on-metal hip
resurfacing implant study, finding that 99% of participants were either
satisfied or extremely satisfied with their implants at 10 years.
British orthopedic titan Smith & Nephew (NYSE:SNN) touted the results of a
10-year study of its metal-on-metal hip resurfacing implants, hoping to
differentiate its implants from the high-profile recall of rival DePuy’s ASR
Smith & Nephew, one of the largest metal-on-metal hip implant makers, is
looking to limit … Read the rest